Fundraising Fox
/Companies
Sign in

Atlas Discovery

YC S26

San Francisco, US · Founded 2026 · 3 employees · 11 known investors

Find your way into Atlas Discovery

Sign up to see every warm intro you have to Atlas Discovery

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Atlas Discovery team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AtlasDiscovery develops foundation models of patient drug response trained on pre-clinical and clinical data to improve drug trial design and success rates. The company serves pharmaceutical and biotech firms by predicting human drug responses and enabling drug rescue and development in the biotech industry.

Also known as Rhizome Bio Inc. · Rhizome Bio

AI & Machine LearningBiotechHealthtechAI-powered Drug DiscoveryDrug discoveryBiotechnologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S26)

Atlas Discovery was founded in 2026 by Sanjukta Bhattacharya and Shaamil Karim.

SBSanjukta Bhattacharya
Sanjukta BhattacharyaCo-FounderSanjukta Bhattacharya is founder of Atlas Discovery, which develops foundation models trained on pre-clinical and clinical data to predict patient drug responses and improve pharmaceutical trial design.
SKShaamil Karim
Shaamil KarimCo-founder and CEOFounder of Atlas Discovery, which builds foundation models of patient drug response trained on pre-clinical and clinical data to improve drug trial design for pharmaceutical and biotech companies. He previously led AI hardware performance modelling at Etched and founded an NFT marketplace in India.
CG
Christian Gensbigler

Investors · 11

Zero Indexlisted by Zero Index

How we know: Y Combinator's founder network · Not right? Tell us

Alumni VenturesreportedManchester · $100K – $10M

How we know: Y Combinator's founder network · Not right? Tell us

FrialereportedNashville · $100K – $600K

How we know: Y Combinator's founder network · Not right? Tell us

General Advancereported

How we know: Y Combinator's founder network · Not right? Tell us

Glasswing VenturesreportedBoston · $100K – $5M

How we know: Y Combinator's founder network · open dataset · 5k.vc investor directory · Not right? Tell us

Lightspeed Venture PartnersreportedMenlo Park · $1M – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Oak HC/FTreportedStamford

How we know: Y Combinator's founder network · Not right? Tell us

Pear VCreportedSan Francisco · $150K – $4M

How we know: Y Combinator's founder network · Not right? Tell us

Residualreported

How we know: Y Combinator's founder network · Not right? Tell us

Ritual CapitalreportedMenlo Park · $100K – $500K

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 4

Paceline BioPlay Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.
AlixiaAlixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.
SFA TherapeuticsSFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases. The company's lead program, SFA-002, is in Phase 2 development for plaque psoriasis, with additional pipeline assets targeting pancreatic cancer, liver cancer, rheumatoid arthritis, and inflammatory bowel disease.
Evolvere BioSciencesEvolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.

Companies working in the same space as Atlas Discovery.

Legal entities · 1

corporate structure
Rhizome Bio Inc.

Frequently asked questions

What does Atlas Discovery do?
AtlasDiscovery develops foundation models of patient drug response trained on pre-clinical and clinical data to improve drug trial design and success rates. The company serves pharmaceutical and biotech firms by predicting human drug responses and enabling drug rescue and development in the biotech industry.
Who founded Atlas Discovery?
Atlas Discovery was founded by Sanjukta Bhattacharya, Shaamil Karim in 2026.
Who are Atlas Discovery's investors?
Atlas Discovery's investors include Y Combinator, Zero Index, Alumni Ventures, Friale, General Advance, Glasswing Ventures, Lightspeed Venture Partners, Oak HC/FT and 3 more.
Where is Atlas Discovery headquartered?
Atlas Discovery is headquartered in San Francisco, US.